Finally, anti-PD1/PD-L1, have recently shown activity in both squamous and adenocarcinoma subtypes of oesophageal cancer and in gastric cancer, and in most studies a correlation between PD-L1 expression and activity was shown. Here, CD274 is linked to carcinoma of esophagus.